|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of LogicBio Therapeutics (NASDAQ: LOGC) through any online brokerage.
The latest price target for LogicBio Therapeutics (NASDAQ: LOGC) was reported by HC Wainwright & Co. on June 7, 2021. The analyst firm set a price target for 15.00 expecting LOGC to rise to within 12 months (a possible 292.67% upside). 2 analyst firms have reported ratings in the last year.
The stock price for LogicBio Therapeutics (NASDAQ: LOGC) is $3.82 last updated Mon Oct 25 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for LogicBio Therapeutics.
LogicBio Therapeutics’s $Q3 earnings are confirmed for after-market on $November 8, 2021.
There is no upcoming split for LogicBio Therapeutics.
LogicBio Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.